Speaker

Kai Wucherpfennig is Chair of the Department of Cancer Immunology and Virology at Dana-Farber Cancer Institute and Professor of Immunology at Harvard Medical School.  His research focuses on the role of cytotoxic T cells and NK cells in cancer immunotherapy.  His lab studies mechanisms of resistance to cancer immunotherapies and develops novel immunotherapy approaches based on these molecular insights.  He has been elected as a member of the American Society for Clinical Investigation (2006), the Henry Kunkel Society at Rockefeller University (2007) and as Fellow of the American Society for the Advancement of Science (2009).

« Go Back